Physician profile
Haidar Yassin
NPI 1659532000
$434,175.42
in general payments reported to CMS, 2019-2025
33 companies · $63K in 2025
The $63K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $27K · 2020: $28K · 2021: $125K · 2022: $66K · 2023: $43K · 2024: $82K · 2025: $63K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $75K · Consulting Fee: $57K · Travel and Lodging: $31K · Food and Beverage: $24K · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $74,925.00 |
| Consulting Fee | $57,250.00 |
| Travel and Lodging | $31,427.38 |
| Food and Beverage | $23,654.98 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $267,349.40 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Pascal, Evoque |
| Boston Scientific Corporation | $96,835.17 | 2019-2025 | Watchman Access System, Watchman Flx, Avvigo Guidance System |
| Ekos Corporation | $22,711.83 | 2019 | |
| Medtronic, INC. | $15,141.08 | 2021-2025 | Corevalve Evolut R, Micra, Harmony |
| W. L. Gore & Associates, INC. | $9,660.13 | 2019-2025 | Gore Cardioform Septal Occluder, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Abbott Laboratories | $7,957.88 | 2019-2025 | Aveir, Triclip, Perclose Prostyle |
| Penumbra, INC. | $4,666.73 | 2021-2025 | Indigo System |
| Abiomed | $3,316.89 | 2019-2025 | Impella |
| Inari Medical, INC. | $1,824.47 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic Vascular, INC. | $1,124.51 | 2019-2020 | |
| Imperative Care, INC | $413.27 | 2025 | Symphony Catheter |
| Shockwave Medical, INC | $411.22 | 2022 | |
| Philips North America LLC | $296.97 | 2019-2025 | Laser Parts Other |
| Teleflex LLC | $286.75 | 2019-2024 | Manta |
| Amgen INC. | $215.00 | 2020-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $212.23 | 2020 | |
| Terumo Medical Corporation | $198.74 | 2019-2024 | Angio-Seal, Glidewire |
| Heartflow, INC. | $184.46 | 2022-2025 | |
| Stryker Corporation | $180.69 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $167.02 | 2022-2025 | Lifevest |
| Livanova USA, INC. | $156.35 | 2021 | |
| Biotronik INC. | $123.05 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $118.77 | 2025 | Camzyos |
| Atricure, INC. | $114.36 | 2019 | |
| B. Braun Interventional Systems INC. | $104.85 | 2025 | Nit-Occlud Pda |
| Asahi Intecc USA, INC. | $89.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $85.53 | 2019-2025 | |
| Chiesi USA, INC. | $60.13 | 2022-2024 | Cleviprex, Kengreal |
| Janssen Pharmaceuticals, INC | $57.14 | 2022-2023 | Xarelto |
| Saranas, INC. | $47.85 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $32.11 | 2024 | |
| Csl Behring | $20.00 | 2024 | Kcentra |
| Btg International INC. | $11.67 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haidar Yassin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.